Arsanis, Inc. logo

Arsanis, Inc.

Arsanis is a leader in the discovery and development of monoclonal antibodies (mAbs) for the targeted immunotherapy of serious infections.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”ASNS” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.arsanis.com
Disease Focus
STOCK CODENASDAQ: ASNS
Address
890 Winter Street, Suite 230, MA 02451-1472
Waltham
United States
Email
Contact Number
+1 781-819-5704

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/arsanis” connections=”true” suffix=””]